Hawk70 don’t be upset I caught you out on a lie because the IND can be submitted at any stage phase as long as the FDA accepts the completion of the phase study and Australia is part of those standards. MSB and AGN went through the same process
So your in human phase 1 study is in next 3-4 months and then we move towards phase 2 next year on submission of IND which will get approved that’s a formality. Your a troll
Keep posting up crock when MSB on rat studies was a 350 million market cap 10 years ago, AGN a 100 million market cap on rat studies 2 years ago. NYR is a 70-100 million dollar market cap biotech as per peers
Hawk70 don’t be upset I caught you out on a lie because the IND...
Add NYR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.3¢ |
Change
0.010(13.7%) |
Mkt cap ! $13.09M | |||
| Open | High | Low | Value | Volume |
| 7.7¢ | 8.3¢ | 7.3¢ | $10.79K | 139.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 47611 | 7.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.3¢ | 2465 | 2 |
View Market Depth
| Last trade - 10.32am 04/06/2024 (20 minute delay) ? |
|
|||||
|
Last
7.3¢ |
Change
0.010 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 7.7¢ | 7.7¢ | 7.3¢ | 77551 | ||
| Last updated 10.19am 04/06/2024 ? | |||||
| NYR (ASX) Chart |